Despite messages to the contrary, most women being seen by a doctor for the first time with suspected heart disease actually experience the same classic symptoms as men, notably chest pain and shortness of breath, according to a study led by the Duke Clinical Research Institute.
Patients recovering from heart attacks or other heart trouble could cut their risk of another heart incident by half if they incorporate stress management into their treatment, according to research from Duke Health.
The Cardiovascular Research Foundation (CRF) is excited to announce the launch of TCTMD’s new podcast network, the Pulse of Cardiology. TCTMD is the leading online resource for cutting-edge news and information in interventional cardiovascular medicine, and beyond.
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II clinical on October 19, 2015. This trial is to assess the safety and efficacy of a vascular implant for the treatment of dissections (tearing in the artery wall) that occur following balloon angioplasty (PTA) of the main artery in the leg.
New research has provided more evidence that an innovative treatment strategy may help prevent brain swelling and death in stroke patients. J. Marc Simard, professor of neurosurgery at the University of Maryland School of Medicine, along with colleagues at Yale University and Massachusetts General Hospital, found that Cirara, an investigational drug, powerfully reduced brain swelling and death in patients who had suffered a type of large stroke called malignant infarction, which normally carries a high mortality rate.
Many Danes are prescribed NSAIDs for the treatment of painful conditions, fever and inflammation. But the treatment also comes with side effects, including the risk of ulcers and increased blood pressure. A major new study now gathers all research in the area. This shows that arthritis medicine is particularly dangerous for heart patients, and also that older types of arthritis medicine, which have not previously been in focus, also appear to be dangerous for the heart.
Ming-Hui Zou has received a four-year, $1.9 million grant from the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health (NIH), to fight cardiovascular disease.
Just published in the Journal of Pediatrics, a long-term study initiated by the Children’s Hospital of Michigan DMC shows how more severe cases of pediatric cardiomyopathy-linked heart disease are associated with reduced “quality of life and functional status,” which can have a negative impact on families of the patients and thus contribute to poor outcomes.
Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being prescribed blood thinners by their cardiologists, according to a new study by researchers at University of California, San Diego School of Medicine and University of California, San Francisco.
Could an unhealthy diet and lack of exercise be making you age faster? Researchers at Mayo Clinic believe there is a link between these modifiable lifestyle factors and the biological processes of aging. In a recent study, researchers demonstrated that a poor diet and lack of exercise accelerated the onset of cellular senescence and, in turn, age-related conditions in mice. Results appear today in Diabetes.
A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient living with a total artificial heart (TAH), a first time event in North Texas. The lifesaving TAH technology, a portable device that pumps blood throughout the body, is used as a "bridge" until a donor heart becomes available.
Ensuring the health and safety of student athletes is a priority at Texas A&M, especially in the Department of Health and Kinesiology and the Health Science Center College of Medicine. Recent research sheds light on the healthy cardiac parameters and blood pressure levels of collegiate athletes.
Obesity, which is associated with low-grade inflammation, is an important contributor in the development of diabetes and cardiovascular disease. While the role of several organs including adipose tissue have been implicated in this process, the cell types and factors driving this process have not been clear. Using a pre-clinical model of obesity, researchers at Brigham and Women's Hospital (BWH) have discovered that a small, non-coding RNA molecule called miR-181b is an important determinant of obesity-induced changes in adipose tissue by controlling the function of the vessels in adipose tissue.
Adults living with congenital heart disease may have a significantly higher risk of post-traumatic stress disorder (PTSD) than people in the general population. Clinicians and caregivers may need to be aware of possible PTSD symptoms, such as anxiety and depression, in their patients.
Bringing new hope to families of children who struggle with a common form of leukemia and thus must confront an elevated risk for long-term heart ailments caused by chemotherapy.
The Valley Hospital in Ridgewood, NJ, is one of 15 U.S. sites currently enrolling patients in a research study to evaluate a potential new treatment alternative for patients with symptomatic persistent and long standing persistent atrial fibrillation (AFib).
The generally accepted medical maxim that elevated HDL cholesterol is “good” has been overturned by a multi-center, international study, They show that a certain genetic cause of increased HDL-C may actually be “bad,” noting that a specific mutation in a gene which encodes a cell receptor protein that binds to HDL prevents the receptor from functioning. It causes an increased risk of heart disease even in the presence of elevated levels of “good” cholesterol.
People newly diagnosed with multiple sclerosis (MS) may often have other chronic health conditions as well, according to a study published in the March 9, 2016 online issue of Neurology®, the medical journal of the American Academy of Neurology.
A 10-year follow-up study of more than 6,000 people who underwent heart CT scans suggests that a high coronary artery calcium score puts people at greater risk not only for heart and vascular disease but also for cancer, chronic kidney disease and chronic obstructive pulmonary disease (COPD).
Published in the upcoming March 10, 2016 issue of the authoritative Journal of Clinical Oncology, this new study is likely to change the standard of cardiac care during treatment of many childhood cancer patients.
Given the high stress levels, extended periods of screen time and regular social outings many Americans experience day-to-day in environments where high-calorie foods are readily available, it can be easy to fall into the habit of mindless eating – where we’re too distracted to pay attention to how much, what and why we’re eating. Research suggests that practicing mindfulness – or taking the time to bring awareness to present-moment experiences with an open attitude of curiosity and non-judgment – can be effective in allowing us to make more thoughtful food choices and recognize when we are hungry, satisfied or full. The latest research in this area led by Jennifer Daubenmier, PhD, Assistant Professor at the Osher Center for Integrative Medicine at the University of California, San Francisco, suggests that the impact of mindful eating could be even greater.
BOSTON – While the protective connection between moderate alcohol consumption and heart health has been well-studied, new research from Beth Israel Deaconess Medical Center (BIDMC) and the Harvard T. H. Chan School of Public Health suggests that the association is more complicated than is widely accepted. Researchers found that in the hour following even moderate consumption of alcohol, the risk of heart and stroke doubled.
Patients with heart failure often have a buildup of scar tissue that leads to a gradual loss of heart function. In a new study, UNC researchers report significant progress toward a novel approach that could shrink the amount of heart scar tissue while replenishing the supply of healthy heart muscle.
Working long hours—particularly 46 hours per week or more—may increase the long-term risk of cardiovascular disease (CVD) events such as heart attack, reports a study in the March Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
When Michael Hess, M.D., started VCU Massey Cancer Center's Cardio-Oncology Program three years ago, it was the first in the state and one of only a handful in the country. Since then, the program has grown exponentially and is still the only one in Richmond dedicated to protecting the hearts of patients undergoing cancer treatment.
A new study from Washington University School of Medicine in St. Louis has identified two genes that, when altered in specific ways, either promote or undermine cardiovascular health. The findings may help guide efforts to design new preventive drugs, similar to the way statins now are prescribed to lower “bad” cholesterol to reduce the risk of heart disease.
Cardiac stem cells could be an effective treatment for a common but difficult-to-treat type of heart failure, a new study from the Cedars-Sinai Heart Institute shows. The study, embargoed until Feb. 29 at 2 p.m. ET, has led to clearance by the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application to test the cells in patients.
A popular smartphone app purported to accurately measure blood pressure simply by placing a cellphone on the chest with a finger over the built-in camera lens misses high blood pressure in eight out of 10 patients, potentially putting users’ health at risk, according to research from Johns Hopkins.
Atherosclerosis, a disease in which plaque builds up inside arteries, is a prolific and invisible killer, but it may soon lose its ability to hide in the body. Scientists have developed a nanoparticle that mimics high-density lipoprotein. It can simultaneously light up and treat atherosclerotic plaques that clog arteries, which could someday help prevent heart attacks and strokes. The researchers present their findings at the 251st National Meeting & Exposition of the American Chemical Society.
With apps and activity trackers measuring every step people take, morsel they eat, and each symptom or pain, patients commonly arrive at doctor's offices armed with self-tracked data. Yet health care providers lack the capacity or tools to review five years of Fitbit logs or instantaneously interpret the deluge of data patients have been collecting about themselves, according to new University of Washington research.
Fluoroscopy makes guiding a catheter through a blood vessel possible. However, fluoroscopy, a form of real-time moving X-ray, also exposes the patient to radiation. Now, a University of Missouri School of Medicine researcher has evaluated technology that may be used to replace fluoroscopy, eliminating the need for X-ray during cardiac ablation procedures.
Andrew DeFilippis, M.D., M.Sc., will study archived blood samples from thousands of patients to determine whether the presence of certain lipids in a person’s bloodstream can be used to pinpoint women at risk for having a heart attack.
At 31, Somerset resident Shawn Fohs was the picture of good health: fit, with no chronic health conditions, and a reputation of never getting sick. But on Aug. 2, an undiagnosed heart condition nearly cost Fohs his life. Using cardiac ablation, a Rutgers cardiac electrophysiologist helped resolve the underlying problem and save his life.
A new study examines whether recent changes in the use of anemia drugs for patients on dialysis have contributed to changes in rates of death or cardiovascular events. The findings indicate that these risks appear to be decreasing for patients on dialysis as well as for older adults not on dialysis. These results suggest that recent trends in the use of anemia drugs in response to US Food and Drug Administration labeling changes and prospective payment for dialysis services have been either neutral or possibly beneficial for patients on dialysis.
A 59-year-old heart patient with dangerously high levels of cholesterol that could not be adequately reduced by statin drugs now has near-normal cholesterol levels, thanks to a new class of drugs that grew out of work done by UT Southwestern Medical Center researchers.
More research needed into the effect of intense exercise on heart structure and function, according to sports cardiologist writing in the Canadian Journal of Cardiology.
The protective effect of heme oxygenase-1 and its mechanism are described. Overexpression of this enzyme could protect the heart from life-threatening damage after cancer chemotherapy, and it also may be a way to increase the therapeutic window of such drugs.
For the first time in the U.S., a clinical trial is underway that’s evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.
For the first time, scientists at The Ohio State University have engineered new calcium receptors for the heart to tune the strength of the heartbeat in an animal model.
Those who struggle with obesity, take heart. Losing as little as 5% of your body weight is enough to reap significant health benefits, according to a study published February 22 in Cell Metabolism. The randomized controlled trial of 40 obese men and women compared, for the first time, the health outcomes of 5%, 10%, and 15% weight loss. While additional weight loss further improved metabolic health, 5% weight loss was sufficient to reduce multiple risk factors for type 2 diabetes and coronary heart disease.
Get the latest news on heart disease, the leading cause of death for people of most ethnicities in the U.S., in the Newswise Heart Disease news source.
Researchers at Washington University School of Medicine in St. Louis have found that in patients with obesity, the greatest improvements to health come from losing just 5 percent of their body weight. That relatively small weight loss lowered patients’ risk for diabetes and cardiovascular disease and improved metabolic function in liver, fat and muscle tissue.
• More than one-quarter of patients with chronic kidney disease may have masked hypertension, meaning that their blood pressure is normal in the clinic but elevated outside the clinic.
• Masked hypertension in patients with chronic kidney disease is linked with an increased risk of kidney, heart, and vascular damage.